 |
 |
 Free Edition - "January 2006" |
Biotech & BioNanotech - Future and Fantasy! It's real, the biotech industry consists of some of the most successful companies in the Life Science sector. At the same time, however, no other industry is so extremely risky regarding investment. Life Science stocks belong to the most volatile investments and their stock prices are mainly driven by study results, patenting, licensing and a lot more good or bad news and announcements. Only the one, who is aware of this dualism is able, on the long term, making money with biotech stocks. Less time and/or missing scientific knowledge are not the only, but the most frequent causes for dramatic losses with biotech stocks. Fact, however, is:Time and the urgently necessary scientific knowledge aren't a 100% guarantee for successful biotech investing, as well. Nevertheless, they significantly minimize the risk of dramatic losses and maximize the change for great profits with biotech and bionanotech stocks. For these reasons, don't hesitate any longer! Decide, still today, for a subscription to the first science based Newsletter in Europe dealing with the worldwide Life Science industry. Secure your first edition and dramatically increase your change for making more profits than losses with biotech and bionanotech stocks. What you get is serious and competent information: Regarding patenting, licensing, research and development (R&D), akquisition and kollaboration (M&A). Regarding companies with substance, as well as to promising speculative candidates. Regarding BlueChips, MidCaps, SmallCaps and MicroCaps. Regarding encouraging technologies, innovative drug candidates and novel therapy approaches. Regarding chances and development risks! |